Effects of WR-2721, a cytoprotector of chemotherapy and radiation on functions of platelet in Chinese healthy volunteers
HUO Guan-Hua, LU Yao-Feng, GAO Hong-Qiu, XU Qing-Rong
2002, 7(6):
518-521.
Asbtract
(
85 )
PDF (170KB)
(
86
)
References |
Related Articles |
Metrics
AIM: To explore in vitro the effects of WR-2721,a cytoprotector of chemotherapy and radiation,on platelet activation induced by physiologic agonists ADP,collagen and PAF.METHODS: Blood,obtained from Chinese healthy volunteers aged 20 -35 years,was treated with physiologic agonists at the given concentrations:ADp1 μmol·L-1,collagen 2 mg·L-1,and PAF0.1 mg·L-1.Then WR-2721 was added to the experimental system at final concentrations range of 10-7 -10-5 mol·L-1.The effect of WR-2721 on platelet aggregation induced by the agonists was studied.Thromboxane B2(TXB2)levels and nitric oxide(NO)production were determined.RESULTS: WR-2721 inhibited both platelet aggregation and TXB2 production induced by ADP,collagen and PAF,in a dose-dependent manner.When WR-2721 was added at the final concentration of 5μmol·L-1,it significantly increased ADP,collagen and PAF-induced NO production,which suggested that NO release by activated platelets was involved in the inhibitory effect of WR-2721.CONCLUSION: WR-2721 can effectively inhibit platelet activation induced in vitro by physiologic agonists.It may be not only a cytoprotectant,but also a therapeutic agent.